ConductScience.org, home

Paper35936713

CD44 Glycosylation as a Therapeutic Target in Oncology.

Liao C and 8 others. Front Oncol, 2022. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. CD44 Glycosylation as a Therapeutic Target in Oncology. Papers, record 35936713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35936713

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD44 Glycosylation as a Therapeutic Target in Oncology.
PubMed
Journal
Front Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
3.23
iCite
Revised in PubMed
2022-08-09
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liao CChengcheng
2Wang QQian
3An JJiaxing
4Chen JJie
5Li XXiaolan
6Long QQian
7Xiao LLinlin
8Guan XXiaoyan
9Liu JJianguo

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References175

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11730766A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion.J Cell Biol1992https://conductscience.org/library/papers/1730766PubMed
232381431Targeting Glycosylation: A New Road for Cancer Drug Discovery.Trends Cancer2020https://conductscience.org/library/papers/32381431PubMed
323190608miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.Cell Death Dis2012https://conductscience.org/library/papers/23190608PubMed
410871609Hyaluronan binding by cell surface CD44.J Biol Chem2000https://conductscience.org/library/papers/10871609PubMed
525116630Terminal sialic acids on CD44 N-glycans can block hyaluronan binding by forming competing intramolecular contacts with arginine sidechains.Proteins2014https://conductscience.org/library/papers/25116630PubMed
625960131Sp1 transcription factor: A long-standing target in cancer chemotherapy.Pharmacol Ther2015https://conductscience.org/library/papers/25960131PubMed
78647947CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix.J Clin Invest1996https://conductscience.org/library/papers/8647947PubMed
810070748Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide.J Biomol NMR1999https://conductscience.org/library/papers/10070748PubMed
927888602A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells.Stem Cells2017https://conductscience.org/library/papers/27888602PubMed
1026190015Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors.Lung Cancer2015https://conductscience.org/library/papers/26190015PubMed
1134093814FUT8 and Protein Core Fucosylation in Tumours: From Diagnosis to Treatment.J Cancer2021https://conductscience.org/library/papers/34093814PubMed
1233466384FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.Int J Mol Sci2021https://conductscience.org/library/papers/33466384PubMed
137532175Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.J Cell Biol1995https://conductscience.org/library/papers/7532175PubMed
1431361756Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway.PLoS One2019https://conductscience.org/library/papers/31361756PubMed
1529792572GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.Nucleic Acid Ther2018https://conductscience.org/library/papers/29792572PubMed
1626663681Role of deltaNp63(pos)CD44v(pos) cells in the development of N-nitroso-tris-chloroethylurea-induced peripheral-type mouse lung squamous cell carcinomas.Cancer Sci2016https://conductscience.org/library/papers/26663681PubMed
1710713114Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action.J Biol Chem2000https://conductscience.org/library/papers/10713114PubMed
1834193268CD44 fucosylation on bone marrow-derived mesenchymal stem cells enhances homing and promotes enteric nervous system remodeling in diabetic mice.Cell Biosci2021https://conductscience.org/library/papers/34193268PubMed
1929957956CD44-Targeted Polymer-Paclitaxel Conjugates to Control the Spread and Growth of Metastatic Tumors.Mol Pharm2018https://conductscience.org/library/papers/29957956PubMed
2031778548Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.Blood2019https://conductscience.org/library/papers/31778548PubMed

See all 175 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
42955118The status quo and evolution of glycoconjugates for cancer immunotherapy.Glycoconj J2026https://conductscience.org/library/papers/42955118PubMed
42919624Siglec-15 and its glycan ligands in tumor-associated macrophage biology and immunotherapy.J Immunother Cancer2026https://conductscience.org/library/papers/42919624PubMed
42855948Encoding Cell-Surface Receptor Function Through Glycosylation: Lessons From CD44.Chembiochem2026https://conductscience.org/library/papers/42855948PubMed
42205480Decoding sialidase: physiological roles, pathological pathways, and clinical opportunities.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42205480PubMed
42191868Mapping galectin-3 ligands in human tear fluid establishes spliceoform-dependent lacritin binding.Commun Biol2026https://conductscience.org/library/papers/42191868PubMed
41850247Spatial tumor evolution panorama of ovarian cancer.Cell Rep Med2026https://conductscience.org/library/papers/41850247PubMed
41667793Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins.Discov Oncol2026https://conductscience.org/library/papers/41667793PubMed
41465476Does Podoplanin (PDPN) Reflect the Involvement of the Immunological System in Coronary Artery Disease Risk? A Single-Center Prospective Analysis.Int J Mol Sci2025https://conductscience.org/library/papers/41465476PubMed
41440277Digging into the Solubility Factor in Cancer Diagnosis: A Case of Soluble CD44 Protein.Biosensors (Basel)2025https://conductscience.org/library/papers/41440277PubMed
41009438CD44 as a Central Integrator of Inflammation and Fibrosis: From Molecular Signaling to Environmental Modulation.Int J Mol Sci2025https://conductscience.org/library/papers/41009438PubMed
40745508Moesin silencing enhances the radiosensitivity of glioblastoma by inhibiting DNA damage repair via CD44/AKT1 signaling pathway.Discov Oncol2025https://conductscience.org/library/papers/40745508PubMed
40667828The Tumour Glyco-Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment.Eur J Immunol2025https://conductscience.org/library/papers/40667828PubMed
40634594Combined downregulation of TGF-β1 and GRP78 is responsible for overcoming acquired sorafenib resistance, which is initiated by rewiring the cell surface CD44-GRP78-IGF-1R signaling circuit.Cancer Gene Ther2025https://conductscience.org/library/papers/40634594PubMed
40507880Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies.Int J Mol Sci2025https://conductscience.org/library/papers/40507880PubMed
40221767The R-RAS2 GTPase is a signaling hub in triple-negative breast cancer cell metabolism and metastatic behavior.J Hematol Oncol2025https://conductscience.org/library/papers/40221767PubMed
40114966CD44 variant exons induce chemoresistance by modulating cell death pathways.Front Cell Dev Biol2025https://conductscience.org/library/papers/40114966PubMed
39860065Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer.Life (Basel)2025https://conductscience.org/library/papers/39860065PubMed
39457544TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells.Biomedicines2024https://conductscience.org/library/papers/39457544PubMed
39333557Elevated α-1,2-mannosidase MAN1C1 in glioma stem cells and its implications for immunological changes and prognosis in glioma patients.Sci Rep2024https://conductscience.org/library/papers/39333557PubMed
38946426Glycosylation in the tumor immune response: the bitter side of sweetness.Acta Biochim Biophys Sin (Shanghai)2024https://conductscience.org/library/papers/38946426PubMed

See all 30 cited byDownload CSV of cited by

Genes62

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BMI1648PubTator's text mininghttps://conductscience.org/library/genes/648NCBI Gene
C1GALT156913PubTator's text mininghttps://conductscience.org/library/genes/56913NCBI Gene
C1GALT1C129071PubTator's text mininghttps://conductscience.org/library/genes/29071NCBI Gene
CD151977PubTator's text mininghttps://conductscience.org/library/genes/977NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
CD53963PubTator's text mininghttps://conductscience.org/library/genes/963NCBI Gene
CD9928PubTator's text mininghttps://conductscience.org/library/genes/928NCBI Gene
CLEC1B51266PubTator's text mininghttps://conductscience.org/library/genes/51266NCBI Gene
CLEC3B7123PubTator's text mininghttps://conductscience.org/library/genes/7123NCBI Gene
CS1431PubTator's text mininghttps://conductscience.org/library/genes/1431NCBI Gene
EEF1A21917PubTator's text mininghttps://conductscience.org/library/genes/1917NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EZR7430PubTator's text mininghttps://conductscience.org/library/genes/7430NCBI Gene
FGF22247PubTator's text mininghttps://conductscience.org/library/genes/2247NCBI Gene
FN12335PubTator's text mininghttps://conductscience.org/library/genes/2335NCBI Gene
FUT12523PubTator's text mininghttps://conductscience.org/library/genes/2523NCBI Gene
FUT42526PubTator's text mininghttps://conductscience.org/library/genes/2526NCBI Gene
FUT62528PubTator's text mininghttps://conductscience.org/library/genes/2528NCBI Gene

See all 62 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35936713

GET https://conductscience.org/api/papers/v1/35936713/references?page=2